The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography
出版年份 2017 全文链接
标题
The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography
作者
关键词
Mycobacterium tuberculosis, Mouse models, Positron emission tomography, Pulmonary imaging, High performance liquid chromatography, Tuberculosis, Microsomes, Radioactivity
出版物
PLoS One
Volume 12, Issue 2, Pages e0170871
出版商
Public Library of Science (PLoS)
发表日期
2017-02-03
DOI
10.1371/journal.pone.0170871
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 18F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography
- (2016) Sean Preshlock et al. CHEMICAL REVIEWS
- Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9
- (2016) Alvaro A. Ordonez et al. Disease Models & Mechanisms
- Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice
- (2016) Scott M. Irwin et al. ACS Infectious Diseases
- Determination of [11C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging
- (2015) Vincent P. DeMarco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Imaging Chronic Tuberculous Lesions Using Sodium [18F]Fluoride Positron Emission Tomography in Mice
- (2015) Alvaro A. Ordonez et al. MOLECULAR IMAGING AND BIOLOGY
- The association between sterilizing activity and drug distribution into tuberculosis lesions
- (2015) Brendan Prideaux et al. NATURE MEDICINE
- Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives
- (2015) Laura E. Via et al. ACS Infectious Diseases
- Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography
- (2014) E. A. Weinstein et al. Science Translational Medicine
- Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection
- (2013) Claudia Manca et al. PLoS One
- Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
- (2013) Shuo Zhang et al. Emerging Microbes & Infections
- Noninvasive Determination of 2-[18F]-Fluoroisonicotinic Acid Hydrazide Pharmacokinetics by Positron Emission Tomography in Mycobacterium tuberculosis-Infected Mice
- (2012) E. A. Weinstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses
- (2011) Kwok Chiu Chang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
- (2011) Jamie Harper et al. JOURNAL OF INFECTIOUS DISEASES
- Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
- (2011) W. Shi et al. SCIENCE
- Mutually Exclusive Genotypes for Pyrazinamide and 5-Chloropyrazinamide Resistance Reveal a Potential Resistance-Proofing Strategy
- (2010) A. D. Baughn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Noninvasive Pulmonary [18F]-2-Fluoro-Deoxy-D-Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug Treatment
- (2009) S. L. Davis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pyrazinamide
- (2008) TUBERCULOSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started